Potomac Capital Management’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
JT
PM
GI
Potomac Capital Management's ATEX Position: Q2 2026 in Review
Potomac Capital Management reduced its Anterix (ATEX) stake by 11% in Q2 2026, selling an estimated $1.1M and leaving 155,071 shares worth $16M. The position accounts for 10.89% of the portfolio, ranked #2.
Potomac Capital Management first reported a position in ATEX in Q4 2025 and has held it in 3 quarters since. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.
- Potomac Capital Management held 155,071 shares of Anterix worth $16M as of Q2 2026.
- Potomac Capital Management sold 18,731 Anterix shares in Q2 2026, an estimated $1.1M.
- Anterix made up 10.89% of Potomac Capital Management's portfolio in Q2 2026, its #2 holding.
- Potomac Capital Management first reported a position in Anterix in Q4 2025 and has held it in 3 quarters since.
- 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.
Based on Potomac Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.